The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study.

Qingnan ZhaoYijiong TanQinqin WuXiangqin XiaoXinyi WeiMengqing NianJie YaoNengguang FanRuiping Wang Guorong Fan

Published in: Expert opinion on drug safety (2023)

Age less than 45 years, concomitant use of Acarbose and insulin were risk factors for Dapagliflozin-associated DK/DKA. Clinicians should watch out for high-risk features among patients with SGLT2i prescription.

Keyphrases

type diabetes
risk factors
wound healing
palliative care
metabolic syndrome
newly diagnosed